/ /

Rose Schneider Krivich
Rose is the content specialist for Medical Economics.
Iridex secures large tender of ophthalmic laser equipment from Zambia government
Iridex has been awarded a competitive tender for more than $350,000 in ophthalmology laser equipment by the government of Zambia.
NASA-backed institute calls on ophthalmic companies for space research help
NASA-backed institute calls on ophthalmic companies for space research help
NASA has struggled to understand why many astronauts, upon returning from space missions, have experienced moderate to severe eye problems and changes to their vision, said Dorit Donoviel, PhD.
Valeant acquires Nicox’s US ophthalmic diagnostics subsidiary
Valeant Pharmaceuticals International has acquired Nicox S.A.’s U.S. diagnostics subsidiary, Nicox, Inc., in a deal worth up to $20 million.
Judge: Yes to Allergan shareholder meeting, but questions Valeant, Pershing Square joint bid
A U.S. district court has ruled that Pershing Square Capital Management can vote its 9.7% stake in Allergan in a special shareholder meeting on Dec. 18.
Richard Zorab, AAO ONE Network founder, dies at 68
Richard Zorab, vice president for ophthalmic knowledge at the American Academy of Ophthalmology, has died at the age of 68.
CMS grants statuses to VisionCare, Omeros products
The Center for Medicare and Medicaid Services (CMS) has granted billing and reimbursement statuses to products from Omeros Corp. and VisionCare Ophthalmic Technologies, respectively.
JJVC unveils natural beauty eye enhancement contact lenses
Johnson & Johnson Vision Care (JJVC) announced the initial launch of 1-Day Acuvue Define brand contact lenses with Lacreon Technology, a new category of eye enhancement contact lenses that accentuate natural beauty while helping to support a healthy eye.
B+L introduces new innovations, products
Bausch + Lomb presented several product innovations in pharmaceuticals, OTC offerings, IOLs, and surgical devices and equipment during the annual meeting of the American Academy of Ophthalmology.
New details about MS, uveitis link revealed in study
The results of the largest retrospective study of multiple sclerosis (MS) in uveitis patients has revealed that nearly 60% of patients with both diseases were diagnosed with each within a 5-year span.
Allergan chief ranked one of the top 5 CEOs in the world by Harvard Business Review
David E.I. Pyott, Allergan’s board chairman and chief executive officer (CEO) has been ranked the 4th best-performing CEO in the world by the Harvard Business Review.